An Isolated TCR αβ Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+ T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Immunology

• Publication date

  2018-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1701054PMID 29555781PMCID PMC5890535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL‐17 and IL‐22 in immunity: Driving protection and pathology

  2017cited by this paper
• Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the JAK2 gene in non-small cell lung cancer

  2017cited by this paper
• Lung Cancer Biomarkers.

  2017cited by this paper
• Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-Analysis.

  2017cited by this paper
• Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients

  2017influential reference
• The Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune System

  2017cited by this paper
• Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells

  2017cited by this paper
• IL-17 induces EMT via Stat3 in lung adenocarcinoma.

  2016cited by this paper
• Preventing tumor escape by targeting a post-proteasomal trimming independent epitope

  2016cited by this paper
• Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches

  2016cited by this paper
• Comprehensive functional characterization of cancer–testis antigens defines obligate participation in multiple hallmarks of cancer

  2015cited by this paper
• Clinical significance of expanded Foxp3+ Helios− regulatory T cells in patients with non-small cell lung cancer

  2015cited by this paper
• Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis

  2015cited by this paper
• Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma

  2015cited by this paper
• 4-1BB Costimulation Ameliorates T Cell Exhaustion Induced by Tonic Signaling of Chimeric Antigen Receptors

  2015cited by this paper
• Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells.

  2015influential reference
• A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets.

  2014cited by this paper
• An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy

  2013cited by this paper
• IL-17A is a central regulator of lung tumor growth

  2012cited by this paper
• IL-17 promoted metastasis of non-small-cell lung cancer cells.

  2012cited by this paper
• Pattern of cancer/testis antigen expression in lung cancer patients

  2012cited by this paper
• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  2011cited by this paper
• Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients.

  2010cited by this paper
• IL-17 Enhances the Net Angiogenic Activity and In Vivo Growth of Human Non-Small Cell Lung Cancer in SCID Mice through Promoting CXCR-2-Dependent Angiogenesis1

  2005cited by this paper
• Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vector

  2004cited by this paper
• Proteasome and peptidase function in MHC-class-I-mediated antigen presentation.

  2004cited by this paper
• Immunomic analysis of human sarcoma

  2003cited by this paper
• Changing T cell specificity by retroviral T cell receptor display.

  2000cited by this paper
• Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.

  1993cited by this paper

• ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers

  2023cites this paper
• Predictive value of TCR Vβ-Jβ profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial

  2022cites this paper
• Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer

  2022cites this paper
• Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms

  2022cites this paper
• Somatic genomic rearrangements in human leucocyte antigens region in solid ovarian tumors

  2021cites this paper
• MUC4 Based Immunotherapy for Pancreatic Cancer

  2018influential citation